35 related articles for article (PubMed ID: 7517476)
1. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
3. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Führlinger S
Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of drugs in peripheral vascular disease and stroke.
Drummond M; Davies L
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S4-7. PubMed ID: 7517476
[TBL] [Abstract][Full Text] [Related]
6. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
7. The stroke therapy research boom: implications for the hospital formulary.
Bender NK
Pharmacotherapy; 1998; 18(3 Pt 2):108S-115S; discussion 85S-86S. PubMed ID: 9619495
[TBL] [Abstract][Full Text] [Related]
8. Naftidrofuryl after acute stroke: a review and a hypothesis.
Steiner TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S58-61. PubMed ID: 1369721
[TBL] [Abstract][Full Text] [Related]
9. The role of health economics within clinical research.
Manns BJ
Methods Mol Biol; 2009; 473():235-50. PubMed ID: 19160742
[TBL] [Abstract][Full Text] [Related]
10. Cost-effective strategies for the management of vascular disease.
West JA
Vasc Med; 1997; 2(1):25-9. PubMed ID: 9546946
[TBL] [Abstract][Full Text] [Related]
11. Costs of stroke using patient-level data: a critical review of the literature.
Luengo-Fernandez R; Gray AM; Rothwell PM
Stroke; 2009 Feb; 40(2):e18-23. PubMed ID: 19109540
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]